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Background: A recent report indicated that numbers of Sutterella spp. are elevated in gastrointestinal biopsies
taken from children with autism spectrum disorder (ASD). We have recently reported changes in the numbers of
some bacteria within the stool of ASD children, and now examine whether numbers of Sutterella spp. and some
other mucosa-associated bacteria linked with gastrointestinal disease (Ruminococcus gnavus and Ruminococcus
torques) are also altered in the stool of these children.
Findings: We show that numbers of Sutterella spp. are elevated in feces of ASD children relative to controls, and
that numbers of R. torques are higher in the children with ASD with a reported functional gastrointestinal disorder
than those without such a disorder.
Conclusions: We show further evidence of changes in the gut microbiota of children with ASD and confirm that
the abundance of Sutterella spp. is altered in stool.
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Autism spectrum disorder (ASD) is a neurodevelopmental
disorder where there is evidence of gastrointestinal (GI)
disturbance in many affected individuals. Several studies
have demonstrated an altered GI microbiota in children
with ASD compared with controls [1-4]. Recently, Williams
et al. [5] reported a significantly higher prevalence of
Sutterella spp. in biopsies taken from the GI tract of ASD
children with GI disturbance compared to controls with
GI disturbance. Bacteria of the genus Sutterella have been
identified in canine and human feces [6,7]. Sutterella
wadsworthensis is noteworthy as it has been associated
with some GI infections in humans [8]. In one study
using culture-based techniques, less than 1% of individ-
uals had detectable fecal levels of S. wadsworthensis,
even among individuals with bowel disorders [9]. How-
ever, in another study, where it was shown that the* Correspondence: michael.conlon@csiro.au
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reproduction in any medium, provided the orabundance of S. wadsworthensis in colonic biopsies of
adults with inflammatory bowel disease (IBD) was not
different from controls, Sutterella appeared to be more
prevalent in the human gut than previously reported [10].
A previous study by our group used quantitative
real-time PCR (QPCR) to compare the abundance of a
range of bacteria in feces of children with ASD, their
siblings and community controls, and demonstrated a
low relative abundance of Bifidobacterium spp. and the
mucolytic bacterium Akkermansia muciniphila in children
with ASD [11]. We have carried out further QPCR ana-
lyses of samples from that study to examine whether
the abundance of Sutterella spp. is also altered in the
feces of children with ASD relative to controls. We
have also examined whether fecal numbers of some
other mucosa-associated bacteria, namely Ruminococcus
torques and Ruminococcus gnavus, are altered in individ-
uals with ASD. As with A. muciniphila, mucosal num-
bers of Ruminococcus species are altered in individuals
with IBD [12].td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ASD (3 without siblings), 22 typically developing siblings
(SIB) and 9 community controls (CON) without a family
history of ASD. The study complied with National Health
and Medical Research Council (Australia) guidelines relat-
ing to ethical conduct in human research. Participants’
caregivers completed a functional GI disorder (FGID)
questionnaire [11]. Procedures for fecal sample collection
and processing, as well as microbial DNA extraction,
have been described previously [11]. QPCR was used to
estimate the abundance of Sutterella spp., R. torques
and R. gnavus in feces using previously described primers
[5,12]. Methods for QPCR, data analysis and primers for
total bacteria were also as reported previously [11]. For
Sutterella, SsoFast™ Probes Supermix was used instead of
EvaGreen® Supermix and an updated version of Bio-Rad
CFX Manager software (Version 2.0) was used. Statistical
analyses were carried out using SPSS for Windows™
(version 17, SPSS Inc., Chicago, IL, USA). Analyses were
carried out using analysis of variance (ANOVA) followed
by Dunnett’s test or by Student’s t-test. A P value of less
than 0.05 was considered statistically significant.
The absolute numbers (per gram of feces) and relative
numbers of bacteria in feces of individuals from the
ASD, SIB and CON groups are presented in Table 1.
Sutterella was detected in the majority of samples ana-
lyzed (ASD 21/23; SIB 19/22; CON 9/9). ANOVA revealed
significantly different absolute and relative numbers of
Sutterella in ASD children compared with sibling and
community controls (P = 0.044 and P = 0.05, respectively).
A post hoc analysis showed significantly increased absolute
and relative numbers of Sutterella in individuals with
ASD compared with community controls (P = 0.028
and P = 0.03, respectively). Moreover, absolute fecal
numbers of Sutterella tended to be higher in siblings
than community controls (P = 0.047). R. torques andTable 1 Numbers of targeted bacteria in feces of children wit
Bacterial targets Bacteria
Autism spectrum disorder (n
Absolute number per gram feces
Sutterella spp. (1.1 ± 0.4) × 106*
R. torques (3.5 ± 1.6) × 105
R. gnavus (4.5 ± 0.7) × 105
Total bacteria (1.2 ± 0.2) × 109
Relative numbers2
Sutterella spp. 3.0 ± 0.7*
R. torques 4.8 ± 1.8
R. gnavus 1.3 ± 0.2
1Means with an asterisk differ from those of community controls. P < 0.05 (one-way
2Relative numbers were calculated using qBase+ [13,14].
ASD autism spectrum disorder.R. gnavus were detected in all fecal samples. Absolute
numbers of R. torques were not significantly higher in
ASD children than in other groups (ANOVA, P = 0.08)
but were higher in siblings relative to community controls
(P = 0.046). Absolute and relative numbers of R. gnavus
did not differ significantly between groups. Significantly
elevated absolute numbers of R. torques were evident in
children with ASD whose caregivers reported them having
a FGID (nine individuals) compared to those without re-
ported FGID (14 individuals) (Student’s t-test, P = 0.008).
There was no significant difference in fecal numbers of
Sutterella or R. gnavus between ASD children with and
without reported FGIDs (data not shown).
Our results demonstrate that numbers of Sutterella are
elevated in the feces of children with ASD relative to com-
munity controls. This confirms and builds on the findings
of Williams et al. [5], who showed high detection rates of
these bacteria in GI biopsies taken from ASD children
with a GI disturbance. In our study there was no evidence
of a difference in numbers of Sutterella between ASD
children with or without caregiver-reported FGID. It is
not yet evident what the consequences of an increase in
fecal Sutterella populations means but it is possible that
under specific conditions these bacteria could cause infec-
tion. Our findings add to the growing list of bacterial
groups whose abundance appears to be altered in the GI
tract of children with ASD. Our results also indicate that
fecal samples may suffice for the detection and quantifica-
tion of Sutterella in the human gut, including children
with ASD. This contrasts with a previous estimation of
detectability and abundance in human fecal samples by
Engberg et al. [9]. Previously it has been difficult to cul-
ture and isolate anaerobic and microaerophilic bacteria,
such as Sutterella, using traditional microbiological tech-
niques and it is likely the QPCR method we employed was
more sensitive than the culture method used by theh ASD, their siblings and community controls
l number (mean ± standard error of the mean)
= 23) Siblings (n = 22) Community controls (n = 9)
(8.7 ± 2.5) × 105* (6.7 ± 4.5) × 105
(4.2 ± 1.5) × 105* (3.5 ± 1.4) × 104
(5.1 ± 0.9) × 105 (2.9 ± 0.4) × 105
(1.4 ± 0.3) × 109 (1.3 ± 0.2) × 109
7.4 ± 3.5* 0.5 ± 0.3
4.8 ± 1.2 1.1 ± 0.2
1.8 ± 0.5 0.6 ± 0.2
ANOVA followed by Dunnett’s test).
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Sutterella in humans are comparable with detection
rates in colonic biopsies from human adults [10].
In this study we also extended our analysis of mucus-
degrading bacteria in feces of ASD children, having
previously shown a low abundance of the mucolytic
bacterium A. muciniphila. We measured the abundances
of R. torques and R. gnavus, both of which can degrade
mucus [15,16] and have been associated with GI disturb-
ance [17]. We have shown there is a trend of increased
fecal numbers of R. torques in ASD children. This pattern
of decreased numbers of A. muciniphila but increased
numbers of R. torques in feces of ASD children is congru-
ent with the pattern observed in the mucosa of adults with
IBD [12]. In the latter study it was also found that growth
of A. muciniphila was inhibited by co-culture with MUC2,
the predominant form of mucin in the large bowel,
whereas this mucin augmented the growth of other
bacteria such as R. torques. Although it is likely that the
populations and activities of microbes that adhere to
the mucus lining the large bowel may differ substan-
tially from those in the feces, it is also likely that some
changes in gut mucosal microbial populations are reflected
in, and hence detectable in, feces. Changes in the amount
of mucus produced may drive changes in mucus-degrading
microbes in both the mucosa and in feces, as mucus can be
incorporated into the fecal stream. Individuals with IBD or
ASD may have changes in large bowel mucus production
that could impact (or are a result of changes in) the muco-
sal barrier of the gut. Indeed, increased gut permeability
has been reported in a subgroup of children with ASD
[18,19]. Further studies that look at gut mucus production
and turnover in children with ASD are warranted.
In summary, we show further evidence of changes in the
gut microbiota of children with ASD, now demonstrating
that fecal abundances of Sutterella and R. torques are
altered (the latter in those reported to have FGID). The
role that these particular bacteria play in ASD is not yet
understood but they may simply reflect larger scale
shifts in the microbial populations as a result of the
condition.
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